Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtre
Ajouter des filtres








Gamme d'année
1.
Gac. méd. Méx ; 134(5): 539-44, sept.-oct. 1998. tab, graf
Article Dans Espagnol | LILACS | ID: lil-234086

Résumé

Se han determinado los niveles de superóxido dismutasa (SOD) y catalasa (CAT) en 420 individuos de uno y otro sexo y edades comprendidas entre 50 y 93 años. De ellos, 126 que no mostraban ninguna enfermedad relevante se utilizaron como grupo control. Los 294 restantes mostraban diferentes trastornos: alteraciones del sistema vascular (insuficiencias coronarias, hipertensión, infarto, etc.), alteraciones del sistema osteoarticular (artritis, polialtralgias, osteoporosis, etc.), miomas, afecciones, prostáticas, enfermedad pulmonar obstructiva crónica (EPOC) y accidente cerebral vascular agudo (ACVA). Para valorar SOD se utilizó el método de minami y Yoshikawa y el método de Aebi para valorar CAT. Métodos estadísticos: ANOVA y "t" de Student. En la población control se han obtenido: 1) niveles de SOD y CAT más elevados en mujeres que en varones. 2) la actividad de CAT disminuye con la edad. En la población con patologías: 3) la actividad de SOD está elevada en cardiovascular, miomas, EPOC y ACVA. 4) la actividad de CAT desciende en cardiovascular, próstata, EPOC y ACVA. 5) en osteoarticular actividad normal de SOD y CAT, aunque SOD desciende con la edad, CAT desciende con la edad en cardiovascular y EPOC. En general el comportamiento de ambos enzimas tiende a conseguir un equilibrio en el sistema antioxidante


Sujets)
Humains , Mâle , Femelle , Sujet âgé , Facteurs âges , Maladies cardiovasculaires/enzymologie , Catalase/sang , Angiopathies intracrâniennes/enzymologie , Interprétation statistique de données , Maladies de la prostate/enzymologie , Maladies osseuses/enzymologie , Maladies articulaires/enzymologie , Léiomyome/enzymologie , Bronchopneumopathies obstructives/enzymologie , Superoxide dismutase/sang , Tumeurs de l'utérus/enzymologie
2.
Braz. j. med. biol. res ; 25(12): 1215-22, 1992. tab
Article Dans Anglais | LILACS | ID: lil-134500

Résumé

1. The angiotensin converting enzyme (ACE) activity of spontaneously hypertensive (SHR) and spontaneously hypertensive stroke-prone (SHRSP) rats was compared to the ACE activity of normotensive Wistar-Kyoto rats (WKY). 2. ACE activity was assessed indirectly in conscious unrestrained rats using the equipressor response end point to simultaneously calculate the extent of conversion of angiotensin I (AI) to angiotensin II (AII) and the pulmonary degradation of bradykinin (BK). 3. The pulmonary degradation of BK was significantly elevated (99.4%) in SHR rats whereas the elevation was not significant in SHRSP rats (99.2%) compared to WKY rats, even though the pulmonary inactivation of BK in WKY rats was higher (98.6%) than in normotensive Wistar rats (95.6% and 97.5%) previously studied. 4. Blood pressure responsiveness to intra-aortically injected BK (bolus injection and infusion) was markedly increased in SHR and SHRSP rats with no change in reactivity to sodium nitroprusside. 5. Conversion of AI to AII assessed by the equipressor doses of the hormones which produced a 20-mmHg rise in blood pressure was markedly elevated in SHR (86 +/- 4%) and SHRSP (80 +/- 7%) rats when compared to WKY rats (38 +/- 4%). 6. The marked increase in conversion of AI to AII in hypertensive animals, accompanied by an increased pulmonary degradation of BK in SHR rats, suggests that ACE activity is increased in conscious SHR and SHRSP rats and may participate in the genesis of hypertension in this model of genetic hypertension


Sujets)
Animaux , Peptidyl-Dipeptidase A/métabolisme , Rats de lignée SHR/métabolisme , Angiotensine-I/administration et posologie , Angiotensine-I/métabolisme , Angiotensine-II/administration et posologie , Angiotensine-II/métabolisme , Pression sanguine/effets des médicaments et des substances chimiques , Bradykinine/administration et posologie , Bradykinine/métabolisme , Angiopathies intracrâniennes/enzymologie , Angiopathies intracrâniennes/génétique , Angiopathies intracrâniennes/physiopathologie , Relation dose-effet des médicaments
SÉLECTION CITATIONS
Détails de la recherche